influenza
virus
major
human
pathogen
caus
annual
epidem
intermitt
pandem
potenti
devast
consequ
vaccin
protect
epidem
influenza
need
repeat
everi
year
due
constantli
chang
viral
surfac
protein
therapi
avail
constitut
defens
pandem
influenza
efficaci
compromis
resist
develop
addit
major
aspect
influenza
pathogenesi
target
cell
type
incomplet
understood
one
constraint
influenza
viru
research
need
quantifi
viral
titer
via
time
labor
intens
techniqu
virus
encod
report
gene
may
constitut
attract
solut
problem
howev
insert
report
gene
viral
genom
complic
task
consid
integr
code
sequenc
requir
effici
viral
spread
cell
cultur
addit
code
noncod
sequenc
end
genom
segment
overlap
essenti
packag
signal
readili
manipul
without
interf
viral
replic
capac
within
previou
strategi
code
sequenc
replac
report
gene
result
virus
suitabl
experiment
analysi
screen
endeavor
requir
propag
cell
line
engin
complement
miss
gene
ideal
addit
report
gene
genom
gener
viabl
stabl
viru
abl
replic
spectrum
target
cell
correspond
wild
type
wt
viru
sever
replicationcompet
influenza
virus
carri
report
gene
describ
date
eleg
approach
design
replic
compet
report
virus
use
manicassami
colleagu
insert
green
fluoresc
protein
gfp
report
segment
flank
complet
gene
gene
arrang
singl
open
read
frame
encod
fusion
protein
connect
via
stopgosequ
termin
translat
follow
reiniti
strategi
circumv
duplic
packag
signal
requir
mutat
splice
acceptor
signal
prevent
splice
segment
viru
use
vivo
detect
influenza
viru
replic
gfp
ideal
suit
due
green
autofluoresc
tissu
also
quantit
cellbas
system
enzymat
report
assay
sensit
one
attract
applic
influenza
report
virus
analysi
viral
entri
target
cell
depend
viral
hemagglutinin
ha
driven
fusion
viral
envelop
endosom
membran
recent
becom
clear
influenza
viru
entri
target
innat
host
cell
encod
antivir
defens
thu
ifitm
protein
block
influenza
viru
infect
stage
viral
entri
polymorph
code
region
modul
suscept
diseas
mechan
underli
antivir
activ
ifitm
protein
incomplet
understood
recent
studi
propos
increas
cholesterol
level
endosom
compart
therebi
inhibit
hadriven
membran
fusion
altern
ifitm
may
impos
structur
constraint
endosom
vesicl
make
fusion
energet
unfavor
character
influenza
report
viru
encod
secret
gaussia
luciferas
enabl
quantif
viru
infect
spread
analysi
enzymat
activ
cell
cultur
supernat
viru
could
use
determin
valu
antivir
substanc
zanamivir
demonstr
inhibit
influenza
viru
infect
protein
cholesterol
modul
agent
initi
step
clone
viral
genom
segment
prepar
modifi
version
revers
genet
vector
allow
bidirect
express
gene
vrna
clone
influenza
viru
segment
made
two
modif
vector
first
chose
use
aari
restrict
site
clone
instead
bsmbi
site
sinc
analysi
sever
laboratori
season
strain
influenza
viru
shown
aari
bsmbi
rare
cut
within
segment
second
insert
cassett
chloramphenicol
resist
gene
neg
select
marker
ccdb
aari
site
ccdb
gene
act
toxin
kill
e
coli
interf
dna
gyras
activ
setup
allow
clone
insert
onepot
restrictionlig
reaction
call
golden
gate
clone
vector
construct
restrict
free
clone
propag
e
coli
bacteria
resist
ccdb
due
mutat
dna
gyras
gene
decid
gener
report
virus
base
publish
design
report
gene
fuse
gene
segment
whole
construct
assembl
pcr
describ
initi
report
clone
addit
report
gene
chose
turborfp
gaussia
luciferas
insert
instead
gfp
restrict
free
clone
fig
assess
express
protein
transfect
newli
construct
plasmid
plasmid
contain
wild
type
segment
cell
analyz
express
protein
immunoblot
protein
express
show
signal
expect
size
fig
absenc
band
correspond
fusion
protein
demonstr
stopgo
signal
effect
amount
luciferas
fusion
protein
cell
lysat
low
compar
wild
type
protein
fusion
protein
sinc
gaussia
luciferas
secret
cell
assess
whether
hold
true
fusion
protein
analyz
luciferas
activ
supernat
cell
lysat
cell
transfect
control
plasmid
gaussia
report
construct
gaussia
report
construct
along
plasmid
encod
influenza
replicas
protein
shown
fig
high
amount
gaussia
luciferas
activ
detect
cultur
supernat
highest
activ
measur
supernat
cell
express
segment
jointli
viral
replicas
protein
demonstr
virtual
gaussia
luciferas
secret
three
segment
encod
differ
report
gene
gfp
turborfp
gaussia
luciferas
allow
reconstitut
infecti
viru
context
growth
three
virus
analyz
singl
step
growth
curv
mdck
cell
infect
multipl
infect
moi
lag
phase
hour
viru
titer
supernat
rapidli
increas
virus
reach
plateau
hour
post
infect
hpi
fig
compar
wild
type
differ
titer
virus
within
log
demonstr
insert
report
gene
compat
rapid
viru
growth
next
analyz
kinet
report
gene
express
mdck
cell
infect
report
virus
carri
fluoresc
report
gene
moi
harvest
fix
time
point
analyz
flow
cytometri
fig
green
fluoresc
emit
detect
earli
hpi
wherea
red
fluoresc
could
detect
hpi
reach
maximum
level
hpi
virus
maximum
cell
infect
analyz
kinet
gaussia
luciferas
express
infect
mdck
cell
incub
cell
presenc
absenc
trypsin
requir
ha
activ
thu
multicycl
replic
influenza
virus
signific
amount
luciferas
activ
detect
earli
hpi
reach
maximum
hpi
fig
luciferas
activ
detect
supernat
cell
cultiv
absenc
trypsin
suggest
gaussia
luciferas
might
inactiv
trypsin
inde
addit
trypsin
complet
abrog
gaussia
luciferas
activ
cultur
supernat
fig
agreement
observ
luciferas
thu
singl
cycl
infect
cell
easili
detect
measur
gaussia
activ
cultur
supernat
experi
assess
viral
spread
must
conduct
presenc
haactiv
proteas
impact
gaussia
activ
membraneassoci
ha
activ
proteas
might
one
suitabl
option
next
investig
stabil
compar
report
gene
activ
cell
infect
virus
differ
passag
moi
fluoresc
virus
fig
fig
show
decreas
percentag
fluoresc
cell
percent
passag
contrast
viru
carri
gaussia
luciferas
rel
stabl
loss
activ
could
observ
passag
howev
point
gaussia
luciferas
activ
infect
cultur
still
log
background
due
high
sensit
higher
stabil
rel
use
report
viru
encod
gaussia
luciferas
experi
high
sensit
simplic
measur
gaussia
luciferas
activ
prompt
us
ask
whether
viru
could
use
inhibitor
test
screen
purpos
first
test
relat
gaussia
luciferas
activ
moi
input
viru
demonstr
fig
observ
loglinear
correl
moi
gaussia
luciferas
activ
log
infecti
dose
level
roughli
moi
addit
analyz
observ
similar
correl
luciferas
activ
output
viru
titer
chose
experiment
setup
measur
multicycl
replic
sinc
could
ensur
activ
influenza
ha
addit
trypsin
cultur
opt
infect
cell
allow
trypsinindepend
influenza
viru
spread
due
endogen
express
infect
cell
low
dose
viru
ffu
moi
supernat
collect
sever
time
point
three
day
post
infect
sampl
luciferas
activ
viru
titer
determin
shown
fig
observ
good
correl
gaussia
luciferas
activ
viru
titer
log
thu
conclud
experi
viru
suitabl
analys
wide
rang
infecti
dose
accordingli
analyz
applic
viru
screen
antivir
substanc
sinc
drug
current
clinic
use
target
neuraminidas
na
act
viru
releas
chose
multicycl
setup
cell
infect
low
dose
viru
ffu
moi
treat
vari
concentr
na
inhibitor
zanamivir
day
post
infect
gaussia
luciferas
activ
determin
supernat
dose
respons
curv
show
clear
inhibit
zanamivir
fig
valu
calcul
nm
rang
known
studi
therefor
viru
suitabl
vitro
test
antivir
activ
zanamivir
like
antivir
compound
numer
natur
antivir
factor
express
upon
interferon
induct
member
ifitm
protein
famili
specif
identifi
inhibitor
influenza
viru
infect
use
protein
determin
whether
viru
suitabl
quantifi
influenza
viru
inhibit
cellular
protein
transduc
mdck
cell
vector
encod
ifitm
chloramphenicol
acetyltransferas
cat
control
gene
subsequ
infect
transduc
cell
moi
absenc
trypsin
determin
gaussia
luciferas
activ
cultur
supernat
express
result
mark
inhibit
infect
cellular
system
test
fig
keep
publish
result
robust
inhibit
infect
also
observ
upon
express
cell
mdck
fig
potenti
due
differ
express
effici
contrast
inhibitori
effect
observ
upon
express
minor
cell
absent
mdck
cell
agreement
publish
data
similar
effect
measur
upon
transduct
ifitm
protein
express
cell
retrovir
vector
bear
ha
na
protein
fig
thu
strongest
inhibit
detect
upon
direct
express
antivir
activ
particularli
less
pronounc
similar
less
pronounc
inhibit
observ
pseudoparticl
bear
vesicular
stomat
viru
vsv
glycoprotein
surfac
inhibit
measur
pseudoparticl
bear
murin
leukemia
viru
envelop
protein
mlv
lassa
viru
lasv
glycoprotein
keep
publish
data
sum
result
indic
use
determin
antivir
activ
host
cell
protein
although
antivir
activ
ifitm
protein
clearli
demonstr
cell
cultur
infect
host
mechan
underli
antivir
action
less
clear
recent
propos
ifitm
protein
might
imped
viral
entri
increas
cholesterol
level
endosom
compart
investig
possibl
test
whether
compound
increas
endosom
cholesterol
inhibit
influenza
viru
entri
inhibit
infect
observ
concentr
test
inhibitori
effect
dose
depend
particularli
pronounc
concentr
fig
result
reproduc
pseudoparticl
bear
influenza
ha
na
fig
confirm
viral
entri
inhibit
final
inhibitori
concentr
nontox
cell
fig
indic
antivir
effect
observ
specif
thu
modul
endosom
cholesterol
level
imped
influenza
viru
infect
gener
influenza
virus
carri
three
differ
report
gene
base
design
publish
manicassami
colleagu
two
recombin
virus
encod
fluoresc
protein
gfp
turbo
rfp
third
viru
encod
gaussia
luciferas
red
fluoresc
protein
advantag
local
studi
tissu
organ
cultur
green
autofluoresc
often
problem
viru
carri
secret
gaussia
luciferas
allow
sensit
detect
infect
without
requir
lyse
infect
cultur
initi
clone
construct
gener
modifi
version
suitabl
clone
onepot
restrictionlig
reaction
call
golden
gate
clone
hand
clone
effici
compar
easier
faster
use
sinc
addit
step
vector
prepar
need
recent
similar
vector
publish
allow
effici
clone
influenza
viru
genom
fusion
protein
express
modifi
genom
segment
expect
size
gaussia
luciferas
activ
readili
detect
supernat
transfect
infect
cell
report
virus
could
reconstitut
grew
like
wild
type
viru
singl
step
growth
curv
maximum
level
report
protein
activ
measur
hpi
report
virus
fluoresc
detect
significantli
earlier
cultur
infect
rel
might
explain
faster
matur
rate
gfp
compar
turbo
rfp
gaussia
luciferas
activ
detect
trypsin
present
medium
presenc
trypsin
halflif
gaussia
luciferas
short
therefor
experiment
condit
requir
addit
trypsin
medium
influenza
viru
activ
need
establish
howev
singl
cycl
experi
carri
present
studi
readili
conduct
absenc
trypsin
fact
singl
cycl
experi
carri
viru
stock
produc
presenc
trypsin
benefit
lack
gaussia
luciferas
activ
viral
inoculum
multipl
round
viru
replic
need
monitor
measur
antivir
activ
zanamivir
necessari
use
cell
line
express
activ
proteas
like
cell
upon
passag
reconstitut
virus
observ
limit
genet
stabil
virus
encod
fluoresc
protein
seem
slightli
stabl
contrast
quit
stabl
first
four
passag
show
reduc
report
activ
later
passag
instabl
also
report
viru
encod
fusion
protein
lack
part
sequenc
reason
genet
instabl
current
clear
two
duplic
region
genom
configur
use
one
exon
ns
gene
one
exon
stop
codon
might
suscept
rna
recombin
moreov
clear
viru
encod
gaussia
luciferas
seem
stabl
fluoresc
virus
howev
upon
prolong
passag
also
observ
reduct
luciferas
activ
viru
recent
differ
influenza
viru
carri
gaussia
luciferas
describ
use
vitro
vivo
character
broadli
neutral
antibodi
viru
exhibit
stabil
compar
gaussia
luciferas
connect
via
sequenc
kdel
signal
retent
endoplasm
reticulum
retent
signal
luciferas
remain
insid
cell
lysi
cell
requir
measur
gaussia
luciferas
activ
viru
well
recent
document
influenza
report
virus
suitabl
vivo
experi
howev
secret
gaussia
luciferas
cell
infect
describ
present
studi
signific
advantag
medium
high
throughput
vitro
assay
prerequisit
effici
screen
compound
librari
novel
antivir
use
quantif
viral
infect
spread
good
correl
infecti
dose
measur
valu
necessari
observ
good
correl
gaussia
luciferas
activ
input
viru
moi
output
viru
two
order
magnitud
infecti
dose
make
system
ideal
quantit
measur
viru
infect
inhibit
antivir
compound
demonstr
measur
effect
zanamivir
drug
current
clinic
use
target
viral
na
employ
cell
measur
valu
nm
valu
close
previous
report
influenza
viru
strain
test
differ
cellular
system
note
caveat
enzymat
na
assay
better
suit
viru
growth
assay
predict
antivir
activ
nai
infect
host
might
consequ
extracellular
mode
action
na
howev
result
demonstr
viru
express
gaussia
luciferas
abl
faith
replic
observ
made
system
authent
influenza
viru
valuabl
tool
futur
identif
character
antivir
compound
cell
encod
sever
antivir
factor
whose
express
induc
interferon
recent
protein
express
induc
type
interferon
describ
possess
potent
antivir
activ
vitro
vivo
far
studi
analyz
antivir
action
ifitm
protein
cell
cultur
reli
use
pseudoparticl
import
find
reproduc
wild
type
influenza
viru
confirm
result
gaussia
luciferas
base
influenza
viru
system
demonstr
block
influenza
viru
infect
recent
suggest
ifitm
protein
might
exert
antivir
activ
increas
cholesterol
level
endosom
compart
increas
endosom
cholesterol
level
increas
size
compart
potenti
inhibit
influenza
viru
infect
current
unknown
found
inhibit
influenza
viru
infect
stage
viral
entri
effect
cholesterol
similar
mutat
niemannpick
cholesterol
transport
ebola
viru
entri
host
cell
depend
bind
proteolyt
process
viral
glycoprotein
entri
inhibit
contrast
influenza
viru
infect
haploid
human
cell
line
defici
observ
suggest
ebola
influenza
viru
entri
requir
express
entri
virus
might
depend
normal
endosom
cholesterol
level
summari
construct
recombin
influenza
viru
encod
gaussia
luciferas
allow
sensit
quantif
infect
minim
manipul
viru
genet
stabl
sever
passag
suitabl
analysi
antivir
action
cellular
factor
chemic
compound
help
screen
evalu
novel
antivir
compound
eight
plasmid
system
low
high
virul
strain
express
plasmid
influenza
replicas
pa
np
pcagg
describ
previous
improv
version
gener
restrict
free
clone
made
two
modif
vector
first
chose
use
aari
clone
instead
bsmbi
origin
vector
sinc
analysi
sever
laboratori
season
strain
influenza
viru
shown
aari
rare
cut
within
segment
second
insert
cassett
chloramphenicol
resist
gene
neg
select
marker
ccdb
aari
site
ccdb
gene
act
toxin
kill
e
coli
interf
dna
gyras
setup
allow
clone
insert
one
pot
restrictionlig
reaction
call
golden
gate
clone
reaction
desir
clone
product
lack
recognit
site
restrict
enzym
relig
catccdb
cassett
occur
cleav
neg
select
transform
convent
e
coli
strain
construct
first
amplifi
fragment
contain
chloramphenicol
resist
ccdb
invitrogen
germani
use
primer
cgagtcggcattttgggccgccgggttattgatcgcaggtgctggctgtgtataagggagcc
gtactggtcgacctccgaagttgggggggagatcgcaggtgttaggcaccccaggctttacac
purifi
fragment
use
second
pcr
reaction
use
templat
add
vector
backbon
dpni
digest
dna
transform
e
coli
select
ampicillin
chloramphenicol
strain
resist
ccdb
due
mutat
dna
gyras
gene
result
plasmid
confirm
restrict
digest
sequenc
plasmid
encod
segment
strain
new
york
kindli
provid
stephan
ludwig
gener
rtpcr
amplif
virion
rna
use
primer
flua
flua
subsequ
golden
gate
clone
plasmid
contain
fusion
construct
describ
gener
rtpcr
amplif
virion
rna
use
primer
flua
flua
clone
start
construct
gener
plasmid
encod
turborfp
gaussia
luciferas
place
gfp
restrict
free
clone
use
primer
templat
use
plasmid
plemir
open
biosystem
pjk
germani
retrovir
vector
express
describ
previous
version
correct
stop
codon
amplifi
clone
pqcxip
use
noti
ecori
construct
control
vector
pqcxipcat
digest
noti
bglii
ligat
pqcxip
digest
noti
bamhi
cat
gene
amplifi
primer
clone
invitrogen
germani
via
xhoi
plasmid
viral
envelop
protein
vesicular
stomat
viru
vsv
mous
leukemia
viru
mlv
lassa
viru
lasv
describ
previous
use
minimum
essenti
medium
earl
salt
mem
paa
cultiv
mdck
ii
cell
dulbecco
modifi
eagl
medium
dmem
invitrogen
cultur
cell
media
supplement
fetal
calf
serum
fc
glutamin
penicillin
streptomycin
cell
cultur
maintain
atmospher
use
dpb
ca
mg
assay
buffer
measur
gaussia
luciferas
activ
supernat
infect
cell
coelenterazin
ad
stock
solut
acidifi
ethanol
final
concentr
measur
firefli
luciferas
activ
cell
harvest
promega
lysi
reagent
mm
trisphosph
ph
mm
dtt
mm
n
acid
glycerol
triton
measur
taken
hidex
plate
chameleon
v
instrument
ms
delay
count
time
immunoblot
cell
lysat
separ
sdspage
blot
onto
nitrocellulos
membran
membran
block
milk
powder
tween
protein
detect
use
antibodi
protein
bound
antibodi
detect
horseradish
peroxidas
hrp
conjug
secondari
antibodi
dianova
dilut
react
luminesc
substrat
amersham
ecl
reagent
ge
healthcar
mixtur
mdck
ii
cell
seed
densiti
cellswel
plate
day
transfect
follow
day
cell
transfect
calcium
phosphat
coprecipit
plasmid
eight
plasmid
system
cell
incub
fc
two
day
place
infect
medium
mem
contain
bovin
serum
albumin
bsa
tpcktrypsin
supernat
harvest
day
transfect
viru
titer
determin
focu
format
assay
viru
stock
passag
higher
gener
inocul
million
mdck
ii
cell
flask
viru
supernat
ml
infect
medium
supplement
tpcktrypsin
infect
cell
incub
total
volum
ml
infect
medium
trypsin
supernat
harvest
h
cell
detach
singl
step
growth
kinet
cell
seed
plate
cellswel
next
day
cell
infect
moi
h
wash
pb
cell
incub
infect
medium
without
tpcktrypsin
certain
time
point
supernat
harvest
frozen
complet
viru
titer
determin
sampl
focu
format
assay
viru
titer
determin
focu
format
assay
briefli
mdck
cell
seed
plate
cellswel
next
day
cell
wash
infect
medium
mem
bsa
without
trypsin
pb
tenfold
dilut
viru
supernat
ad
incub
h
remov
inoculum
dmem
contain
avicel
fmc
biopolym
tpcktrypsin
sigma
ad
plate
incub
overnight
detect
viru
infect
cell
first
avicel
contain
medium
remov
cell
wash
time
pb
fixat
paraformaldehyd
wash
quench
pb
triton
mm
glycin
block
pb
triton
bsa
cell
incub
primari
polyclon
goat
antibodi
rais
influenza
viru
millipor
secondari
antigoat
hrpconjug
antibodi
kpl
incub
step
follow
wash
step
final
cell
react
hrpsubstrat
true
blue
kpl
blue
spot
becam
visibl
foci
count
viral
titer
calcul
focu
form
unit
ffu
correl
luciferas
activ
output
viru
measur
zanamivir
sensit
cell
seed
plate
cellswel
next
day
cell
infect
ffuwel
h
cell
incub
medium
without
trypsin
supernat
harvest
frozen
everi
h
three
day
sampl
luciferas
activ
viru
titer
determin
linear
regress
analysi
perform
microsoft
excel
pvalu
calcul
excel
addin
daniel
xl
toolbox
version
http
xltoolboxsourceforgenet
analysi
zanamivir
sensit
cell
infect
ffuwel
h
wash
pb
medium
contain
zanamivir
sigma
aldrich
ad
cell
zanamivir
dilut
medium
mm
stock
solut
final
concentr
nm
nm
nm
nm
nm
supernat
harvest
day
gaussia
luciferas
activ
determin
valu
calcul
use
graphpad
prism
softwar
cholesterol
modul
agent
cayman
chemic
compani
usa
dissolv
dmso
measur
inhibit
influenza
viru
infect
cell
seed
plate
cellswel
next
day
cell
incub
h
dmso
control
concentr
higher
final
concentr
obtain
upon
addit
viru
equal
volum
medium
contain
viru
ad
supernat
harvest
h
gaussia
luciferas
activ
measur
cell
transduc
retrovir
vector
infect
h
complet
transduct
influenza
moi
h
thereaft
medium
replac
infect
medium
without
trypsin
supernat
harvest
h
gaussia
luciferas
activ
measur
cell
viabil
presenc
dmso
determin
use
bromid
mtt
base
cell
viabil
assay
briefli
cellswel
preincub
inhibitor
concentr
use
infect
experi
h
equal
volum
medium
ad
obtain
final
inhibitor
concentr
cell
incub
h
medium
chang
vol
mtt
stock
solut
ad
incub
h
humidifi
atmospher
formazan
salt
dissolv
addit
acidifi
isopropanol
absorpt
nm
measur
elisa
plate
reader
absorpt
untreat
cell
set
product
retrovir
vector
encod
ifitm
protein
pqcxipbas
vector
encod
ifitm
protein
cat
mlvgagpol
plasmid
vsvg
express
plasmid
calcium
phosphat
transfect
cell
seed
flask
cultur
medium
exchang
h
post
transfect
supernat
harvest
day
post
transfect
supernat
pass
filter
store
produc
mlv
report
particl
pseudotyp
differ
viral
glycoprotein
cell
seed
confluenc
transfect
flask
use
calcium
phosphat
precipit
plasmid
encod
mlv
gag
pol
plasmid
encod
luciferasebear
mlv
vector
plasmid
encod
viral
entri
protein
wsn
hana
lasvgpc
envelop
protein
mlv
glycoprotein
vsv
hour
transfect
supernat
harvest
filter
measur
inhibit
hadriven
viral
entri
cell
seed
plate
densiti
cell
per
well
one
hour
infect
wsn
hanapseudotyp
mlvparticl
cell
preincub
medium
contain
two
time
final
inhibitor
concentr
one
hour
pseudotyp
ad
cell
incub
hour
thereaft
supernat
remov
fresh
medium
without
inhibitor
ad
cell
fireflyluciferas
activ
cell
lysat
analyz
h
infect
gener
ifitm
express
cell
cell
cell
state
otherwis
seed
plate
densiti
cell
per
well
adher
cell
transduc
ifitm
encod
mlvbase
vector
see
centrifug
min
room
temperatur
transduc
cell
coincub
infect
medium
hour
supernat
replac
fresh
medium
subsequ
cell
inocul
infectivitynorm
pseudotyp
incub
hour
thereaft
supernat
remov
fresh
cultur
medium
ad
per
well
firefli
luciferas
activ
analyz
h
transduct
